Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases

By sjmartinez • December 25, 2024

Aringer M, Distler O, Hoffmann-Vold AM, Kuwana M, Prosch H, Volkmann ER. Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases. RMD Open. 2024 Dec 23;10(4):e004704. doi: 10.1136/rmdopen-2024-004704. PMID: 39719300.

Tags: Autoimmune Diseases, Publications, Pulmonary fibrosis, Rheumatology, Therapeutics

Symptom Burden After Dialysis Initiation and Its Association With Hospitalization

Nair D, Cai X, Hays RD, Aiyegbusi OL, Frazier RS, Isakova T, Peipert JD. Symptom Burden After Dialysis Initiation and Its Association With Hospitalization. Kidney[...]

A Case of Thyroid Dermopathy

Day AJ, Sarantopoulos GP. A Case of Thyroid Dermopathy. Cureus. 2026 Jul 29;18(7):e113624. doi: 10.7759/cureus.113624. PMID: 42668724; PMCID: PMC13525185.

Calpeptin Reduces Extracellular Vesicle Secretion and Induces Anti-Inflammatory Effects but Upregulates HO-1 and Alters Adiponectin Levels in Human Adipocytes

Matilainen J, Foster S, Berg V, Tampio J, Turunen T, Mustonen AM, Kyykallio H, Vaittinen M, Männistö V, Pihlajamäki J, Malinen M, Oikari S, Käkelä[...]